ID: ALA4789226

Max Phase: Preclinical

Molecular Formula: C13H13NO3

Molecular Weight: 231.25

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  C=C1C(=O)O[C@@H]2CCCn3c(C=O)ccc3[C@@H]12

Standard InChI:  InChI=1S/C13H13NO3/c1-8-12-10-5-4-9(7-15)14(10)6-2-3-11(12)17-13(8)16/h4-5,7,11-12H,1-3,6H2/t11-,12-/m1/s1

Standard InChI Key:  LNXBVCPZPORMEI-VXGBXAGGSA-N

Associated Targets(Human)

HCT-8 3484 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 231.25Molecular Weight (Monoisotopic): 231.0895AlogP: 1.66#Rotatable Bonds: 1
Polar Surface Area: 48.30Molecular Species: HBA: 4HBD: 0
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 1.54CX LogD: 1.54
Aromatic Rings: 1Heavy Atoms: 17QED Weighted: 0.42Np Likeness Score: 1.07

References

1. Ma K,Zhang M,Wu X,Yang P,Yin C.  (2021)  Discovery of a potent β-catenin destabilizer for overcoming the resistance of 5-fluorouracil in colorectal cancer.,  30  [PMID:33321421] [10.1016/j.bmc.2020.115929]

Source